Logo

Novartis Plans to Align its Production with Expected Lower Prices in the US

Share this
Novartis Plans to Align its Production with Expected Lower Prices in the US

Novartis Plans to Align its Production with Expected Lower Prices in the US

Shots:

  • Novartis plans to increase its worldwide operating profit margins by making production efficient- in spite of dipping in prices for its drugs in the US
  • The company aims to increase efficiency of pharma business from 32% to 35% within five years
  • As per Novartis chairman- drug prices are rising in Europe and Novartis can charge slightly higher or stable prices in Europe
  • Cuplikan Olahraga

/ article | Ref: Reuters | Image:  Novartis


Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions